5-hydroxymethylcytosine has been researched along with Genetic Predisposition in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Christiani, DC; Du, M; Guo, Y; Hou, L; Hutchinson, JN; Lin, X; Mucci, LA; Su, L; Wang, J; Wang, Z; Yuan, Q; Zheng, Y | 1 |
Feng, F; Li, Y; Ren, Q; Sun, S; Wang, X; Wu, D; Zhang, M; Zhu, H | 1 |
Arif, M; Becker, RC; Elbeck, Z; Knöll, R; Sadayappan, S; Song, T; Tabish, AM | 1 |
Hornick, JL; Mason, EF | 1 |
Gao, F; Huang, J; Lin, Z; Liu, W; Liu, X; Luo, H; Ou, Y; Wang, J; Wen, B; Xia, Y; Zhang, X; Zhou, B | 1 |
Chen, YS; Chong, ZC; Jiao, J; Li, D; Sun, BF; Wang, XL; Wang, XX; Zhao, Y; Zhou, YM | 1 |
Castaño, GO; Dopazo, H; Gianotti, TF; Martino, JS; Pirola, CJ; Rohr, C; Scian, R; Sookoian, S | 1 |
Maunakea, AK; Pang, AP; Sugai, C | 1 |
Li, H; Luan, P; Peng, W; Wang, K; Xu, Y; Zhang, P; Zhuang, J | 1 |
Ahn, JS; Ahn, SY; Choi, SH; Jang, JH; Jung, CW; Jung, SH; Kim, DD; Kim, HJ; Kim, SH; Kim, YK; Lee, JJ; Lee, SS; Michael, S; Minden, MD; Moon, JH; Park, HJ; Sohn, SK; Won, JH; Yang, DH | 1 |
1 review(s) available for 5-hydroxymethylcytosine and Genetic Predisposition
Article | Year |
---|---|
High-throughput sequencing offers new insights into 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; High-Throughput Nucleotide Sequencing; Humans; Organ Specificity | 2016 |
9 other study(ies) available for 5-hydroxymethylcytosine and Genetic Predisposition
Article | Year |
---|---|
Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Computational Biology; CpG Islands; Disease Susceptibility; DNA Methylation; Epigenesis, Genetic; Epigenomics; Gene Expression Profiling; Genetic Loci; Genetic Predisposition to Disease; Humans; Lung Neoplasms | 2020 |
Combined 5-hydroxymethylcytosine content of human leucocyte antigen-B and human leucocyte antigen-DQB1 as novel biomarker for anti-tuberculosis drug-induced liver injury.
Topics: 5-Methylcytosine; Adult; Antitubercular Agents; Biomarkers; Case-Control Studies; Chemical and Drug Induced Liver Injury; DNA Methylation; Female; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DQ beta-Chains; Humans; Male; Middle Aged; Tuberculosis | 2020 |
Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy.
Topics: 5-Methylcytosine; Animals; Cardiomyopathy, Dilated; Carrier Proteins; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Regulatory Networks; Genetic Predisposition to Disease; Hydroxylation; Introns; Male; Mice, Mutant Strains; Mutation; Phenotype; Promoter Regions, Genetic; Transcriptome; Ventricular Function, Left | 2019 |
Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cell Transformation, Neoplastic; Cytosine; DNA Mutational Analysis; Down-Regulation; Electron Transport Complex II; Exons; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Membrane Proteins; Mutation; Phenotype; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor alpha; Succinate Dehydrogenase | 2013 |
Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma.
Topics: 5-Methylcytosine; Activating Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Comparative Genomic Hybridization; Cytosine; DNA Methylation; Epigenesis, Genetic; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Molecular Sequence Data; Promoter Regions, Genetic; Sequence Analysis, DNA; T-Box Domain Proteins | 2014 |
Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia.
Topics: 5-Methylcytosine; Case-Control Studies; Cell Shape; Cytosine; DNA; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomic Imprinting; Humans; Infertility, Male; Male; Phenotype; Sperm Motility; Spermatogenesis; Spermatozoa | 2015 |
Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.
Topics: 5-Methylcytosine; Adult; Cytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Heat-Shock Proteins; Humans; Liver; Male; Middle Aged; Mitochondria, Liver; Mixed Function Oxygenases; Non-alcoholic Fatty Liver Disease; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proto-Oncogene Proteins; Transcription Factors | 2015 |
The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Topics: 5-Methylcytosine; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azacitidine; Cell Dedifferentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Decitabine; Diet, High-Fat; Dioxygenases; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Signal Transduction; Time Factors; Trans-Activators; Vascular Remodeling | 2017 |
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Dioxygenases; Disease Progression; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Phenotype; Predictive Value of Tests; Proportional Hazards Models; Proto-Oncogene Proteins; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2017 |